NEJM Evid 润色咨询

NEJM Evidence

出版年份:2022 年文章数:暂无数据 投稿命中率: 开通期刊会员,数据随心看

出版周期:monthly 自引率:暂无数据 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=1c5627426, cover=https://img.medsci.cn/202241/1648818625905_4754896.jpg, fullname=NEJM Evidence, abbr=NEJM Evid, pyear=2022, frequence=monthly, articleNumbers=null, citedSelf2015=null, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均3.2月, reviewFee=null, pageFee=null, publishedRatio=, issn=2766-5526, greenSci=https://www.greensci.net/search?kw=2766-5526, scijournal=https://www.scijournal.org/impact-factor-of-NEJM-Evid.shtml, medsciHotlightString=null, medsciHotlightRealtime=4.354, medsciHotlight=null, medsciHotlight5year=null, citescore=null, hIndex=null, impactFactor=null, orgnization=NEJM Group, orgnizationUrl=https://evidence.nejm.org/, country=USA, countryCn=美国, isOa=3, isOaString=部分OA, sciScie=null, bigclassCas=null, smallclassCas=0, website=https://evidence.nejm.org/, websiteHits=4059, guideForAuthor=https://evidence.nejm.org/author-center, guideForAuthorHits=3203, submitWebsite=https://mc05.manuscriptcentral.com/evidence, submitWebsiteHits=3194, content=<p><em style="color: #1a1a1a;">NEJM Evidence</em><span style="color: #1a1a1a;">, a new monthly digital journal from NEJM Group, presents innovative original research and fresh, bold ideas in clinical trial design and clinical decision-making.</span></p> <p>The volume of clinical research continues to grow, yet the standards to establish and validate claims, especially as related to clinical practice, have not followed suit. <em>NEJM Evidence</em> expands the corpus of published research with a focus on providing more context and critical evaluation of the methods and results to support clinical decision-making and does so in a way that respects the time and commitment of the practitioner.</p> <p><span style="color: #1a1a1a;"><em>NEJM Evidence</em> seeks to advance clinical trial research and clinical practice by:</span></p> <ul> <li>Publishing high-quality studies from the front lines of medical research.</li> <li>Challenging the medical community to take new approaches to clinical trial design and execution that yield more powerful clinical evidence.</li> <li>Sparking debate and conversation around areas of medicine where clinical decisions are made without sufficient evidence.</li> <li>Engaging physicians in a more sophisticated and meaningful way with clinical evidence.</li> </ul> <p><span style="color: #1a1a1a;">Adhering to the rigorous peer-review and quality standards expected from NEJM Group, <em>NEJM Evidence</em> publishes:</span></p> <ul> <li>Original research, clinical trials, and other clinically grounded work (e.g., epidemiology studies, first-in-human trials, meta-analyses) that validate or challenge prior clinical findings.</li> <li>Standard reviews, systematic reviews, and other review types that contextualize research findings with the aim of accelerating clinical adoption of new evidence.</li> <li>Case studies and reviews of clinical trial methodology that enhance understanding of trial strengths and weaknesses.</li> <li>Curbside consult series that addresses common patient care issues.</li> <li>Morning Report series solicited case presentation articles that are delivered in a morning report format.</li> </ul> <p><span style="color: #1a1a1a;">Unique content and features include:</span></p> <ul> <li><em>Tomorrow’s Trial</em>, a series of short pieces that highlight accepted practices lacking solid evidence and inviting clinician readers to propose clinical trials to fill those gaps.</li> <li><em>Patient Platform</em>, in which patients who have been in a clinical trial, part of a research study, or had their care impacted strongly by these, share their thoughts on their experience.</li> <li><em>Stats, STAT!</em>, a brief animated video explaining a statistical concept based on a statistical review.</li> </ul> <h3 style="color: #000000;">Generation of Evidence</h3> <p>The process of generating evidence is a key area of focus for <em>NEJM Evidence</em>. We encourage readers to evaluate the reasoning behind the complex decisions that investigators make in trial design and execution, and to assess the quality of evidence produced in trials. Our goal is to build a community that takes a rigorous approach to evaluating evidence and assessing its impact on clinical decision-making.</p> <h3 style="color: #000000;">Statistical Methods</h3> <p><em>NEJM Evidence</em> guides readers toward a deeper understanding of the statistical methods used in trials. We provide concise, digestible explanations of research methods to inform the interpretation of the resulting data. In addition, we introduce readers to emerging statistical methods and types of data that will play an increasingly prominent role in future trials.</p> <h3 style="color: #000000;">Multidisciplinary Coverage</h3> <p><em>NEJM Evidence</em> publishes content relevant across all medical disciplines to advance the discussion of how to generate evidence that informs patient care. Physician-scientists, trialists, and general medicine and subspecialty clinicians will all benefit from this publication.</p>, totalCites=null, brief=NEJM Evid杂志暂不明确行业,暂不明确子行业的级别不明杂志, articleType=本刊接收类型不明, medsciHeat=<span style="color: #000000;">黑</span>, medsciComment=杂志水平一般,也很冷门,关注人少,审稿周期可能也不一定快,如果文章质量不佳,或时间不紧的话,可以考虑考虑。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=1c5627426'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=340, tagName=Meta分析, createdHits=6), ImpactFactorTagDto(id=41285, tagName=医学综合, createdHits=3), ImpactFactorTagDto(id=109, tagName=临床试验, createdHits=2), ImpactFactorTagDto(id=266, tagName=心血管, createdHits=1)], citeScoreList=null, medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=22.802), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=13.046), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=4.354)], citeScoreGradeList=[], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2766-5526[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=NEJM Evidence[ta], article_number=null, article_number_cn=null, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
NEJM Evid/NEJM Evidence
ISSN
2766-5526
影响指数话题
预警等级
MedSci期刊指数
4.354 (MedSci实时期刊指数) | 暂无数据 (5年期刊指数)
CiteScore值
暂无数据
h-index
暂无数据
h5-median
暂无数据
出版社/管理机构
杂志由 NEJM Group 出版或管理
出版国家/地区
USA 美国
出版周期
monthly
出版年份
2022
是否OA
部分OA
被收录情况
暂无数据
JCR分区
暂无数据
中科院分区
大类:
小类:0